Latest Sanofi News & Updates

See the latest news and media coverage for Sanofi. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sanofi

R&D-driven, AI-powered biopharmaceutical company

sanofi.com

Headquarters: Paris, France
Company type: Public company
Number of employees: 90,000+

Last updated Today

Latest news about Sanofi

In short: Sanofi advanced its pipeline with key approvals for Sarclisa and Tzield while expanding its AI capabilities through global hubs and partnerships.

Company announcements

Yesterday Sanofi

Sanofi's Wayrilz approved in Japan for immune thrombocytopenia

Approval based on LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other symptoms.

Yesterday Sanofi

Sanofi's Cenrifki approved in EU for SPMS without relapses

Approved based on HERCULES study showing delayed disability progression. It targets smoldering neuroinflammation, requiring liver monitoring.

June 22 Sanofi

Sanofi appoints Paulo Fontoura as Global Head of R&D

He will succeed Houman Ashrafian and lead R&D Pharma, reporting to CEO Belén Garijo.

June 19 Sanofi

Sanofi's Sarclisa SC approved in Japan for multiple myeloma

Approval based on IRAKLIA phase 3 study showing non-inferior efficacy vs IV, with potential for on-body injector.

Media coverage

Yesterday The Globe and Mail

Sanofi Wins FDA Accelerated Approval for Tzield in Newly Diagnosed Stage 3 Type 1 Diabetes Children

Sanofi ( (SNY)) has provided an announcement. On June 13, 2026, the U.S. Food and Drug Administration granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) as...

Yesterday The Guardian

Drug that delays onset of type 1 diabetes approved in England and Wales

Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ’incredible moment...

Yesterday The Wall Street Journal

Sanofi Multiple Sclerosis Drug Gets EU Approval

The authorization of Cenrifki for the treatment of secondary progressive multiple sclerosis without relapses follows a rejection from U.S. drug...

Yesterday Boursier.com

Sanofi: Wayrilz approved in Japan to treat immune thrombocytopenia

(Boursier.com) — The Japanese Ministry of Health, Labor and Welfare has granted marketing authorization and...

Never miss news about Sanofi

Track Sanofi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sanofi competitors & trending companies

Browse news for competitors to Sanofi and other trending companies.